Influence of Chemotherapy on <i>EGFR</i> Mutation Status Among Patients With Non–Small-Cell Lung Cancer

Abstract

Our results suggest that chemotherapy may reduce EGFR mutation frequency in patients with NSCLC, likely the result of a preferential response of subclones with EGFR mutations in tumors with heterogeneous tumor cell populations.